Major Pharmaceuticals: Levothyroxine Sodium Tablets, Usp, 125 Mcg (0.0125 Mg), 10 Tablets (10 X 1) Unit Dose Blisters Per Carton

Levothyroxine Sodium Tablets Recall Summary Major Pharmaceuticals is recalling 125 mcg levothyroxine sodium tablets (a thyroid medication) distributed nationwide because the tablets contain less active ingredient than labeled. This is a Class II recall affecting patients in all U.S. states who received these tablets in unit dose blisters packaged by Major Pharmaceuticals and distributed by Cardinal Health.

Recalling firm

Major Pharmaceuticals

Product

Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3562-0; NDC Blister: 0904-6951-61

Reason

Subpotent Drug

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-07-13

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide in the USA.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/f363778e-28d2-4a42-bb57-74c384f5e4ec